BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37909210)

  • 1. Impact of the COVID-19 pandemic on clinical presentation, treatments, and outcomes of new breast cancer patients: A retrospective multicenter cohort study.
    Guével E; Priou S; Lamé G; Wassermann J; Bey R; Uzan C; Chatellier G; Belkacemi Y; Tannier X; Guillerm S; Flicoteaux R; Gligorov J; Cohen A; Benderra MA; Teixeira L; Daniel C; Hersant B; Tournigand C; Kempf E;
    Cancer Med; 2023 Nov; 12(22):20918-20929. PubMed ID: 37909210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No changes in clinical presentation, treatment strategies and survival of pancreatic cancer cases during the SARS-COV-2 outbreak: A retrospective multicenter cohort study on real-world data.
    Kempf E; Priou S; Lamé G; Laurent A; Guével E; Tzedakis S; Bey R; Fuks D; Chatellier G; Tannier X; Galula G; Flicoteaux R; Daniel C; Tournigand C;
    Int J Cancer; 2023 Dec; 153(12):1988-1996. PubMed ID: 37539961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study.
    Priou S; Lamé G; Zalcman G; Wislez M; Bey R; Chatellier G; Cadranel J; Tannier X; Zelek L; Daniel C; Tournigand C; Kempf E;
    Eur J Cancer; 2022 Sep; 173():33-40. PubMed ID: 35843177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of university hospitals.
    Kempf E; Priou S; Lamé G; Daniel C; Bellamine A; Sommacale D; Belkacemi Y; Bey R; Galula G; Taright N; Tannier X; Rance B; Flicoteaux R; Hemery F; Audureau E; Chatellier G; Tournigand C;
    Int J Cancer; 2022 May; 150(10):1609-1618. PubMed ID: 35001364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021.
    Malmgren JA; Guo B; Atwood MK; Hallam P; Roberts LA; Kaplan HG
    Breast Cancer Res Treat; 2023 Nov; 202(1):105-115. PubMed ID: 37584882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in breast cancer staging trends among Egyptian women after COVID-19: A retrospective single-center study.
    Abd El Wahab MH; Ibrahim AH; Gado O; Bahbah AM; Fadlalla W; Fakhry S; Mamdouh MM; Kamel MM; Moaz I; Rabea A; Helal AM
    Int J Immunopathol Pharmacol; 2023; 37():3946320231152835. PubMed ID: 36649477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly specialized Breast Centers did not experience delay of care during COVID-19 pandemic in Italy: the Senonetwork experience.
    Losurdo A; Lisa AVE; Tomatis M; Ponti A; Montemezzi S; Bonzano E; Fortunato L;
    Breast Cancer Res Treat; 2022 Nov; 196(1):87-95. PubMed ID: 36018455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of the COVID-19 pandemic on breast cancer management: Experience of a French Comprehensive Cancer Center].
    Tran M; Brouard N; Hequet D; Rouzier R; Donval L
    Bull Cancer; 2022 Dec; 109(12):1236-1244. PubMed ID: 36229268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Care and Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Newly Diagnosed Stage IV or Recurrent Disease Undergoing First-line Trastuzumab-based Therapy: A Multicenter Retrospective Cohort Study.
    Lambertini M; Ferreira AR; Di Meglio A; Poggio F; Puglisi F; Sottotetti F; Montemurro F; Poletto E; Bernardo A; Risi E; Dellepiane C; Sini V; Minuti G; Grasso D; Fancelli S; Del Mastro L
    Clin Breast Cancer; 2017 Dec; 17(8):601-610.e2. PubMed ID: 28479052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients.
    Triki M; Zghal M; Ayed HB; Makni S; Bouhamed M; Fendri S; Charfi S; Boudawara T; Mellouli M
    Breast Dis; 2024; 43(1):9-17. PubMed ID: 38363601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study.
    Mentrasti G; Cantini L; Vici P; D'Ostilio N; La Verde N; Chiari R; Paolucci V; Crocetti S; De Filippis C; Pecci F; Di Lisa FS; Traisci D; Cona MS; Nicolardi L; Pizzuti L; Gildetti S; Oldani S; Della Mora A; Bruno Rocchi ML; Berardi R
    Breast; 2022 Oct; 65():164-171. PubMed ID: 35998429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer and SARS-Cov2: Lessons from a Pandemic.
    Gosset M; Gal J; Schiappa R; Helwig C; Bonomo I; Delpech Y; Barranger E
    Anticancer Res; 2023 May; 43(5):2235-2241. PubMed ID: 37097690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective.
    Knoll K; Reiser E; Leitner K; Kögl J; Ebner C; Marth C; Tsibulak I
    Arch Gynecol Obstet; 2022 Apr; 305(4):945-953. PubMed ID: 34559295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective.
    Tsibulak I; Reiser E; Bogner G; Petru E; Hell-Teutsch J; Reinthaller A; Weirather C; Weiss T; Bozsa S; Puschacher B; Hall M; Hittler D; Hrauda K; Thell E; Clauss S; Pozniak J; Alicke S; Gangl D; Gamperl G; Ebner C; Knoll K; Leitner K; Schilcher A; Schinnerl M; Sigl V; Singer C; Aigmüller T; Hofstätter B; Marth C
    Int J Gynecol Cancer; 2020 Nov; 30(11):1667-1671. PubMed ID: 33033166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy to the primary tumor for de novo metastatic breast cancer and overall survival in a retrospective multicenter cohort analysis.
    Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Rivera S; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; De La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Courtinard C; Filleron T; Robain M; Dalenc F
    Radiother Oncol; 2020 Apr; 145():109-116. PubMed ID: 31931289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management.
    Tonneson JE; Hoskin TL; Day CN; Durgan DM; Dilaveri CA; Boughey JC
    Ann Surg Oncol; 2022 Apr; 29(4):2231-2239. PubMed ID: 34812981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
    Tran C; Cipriano LE; Driman DK
    CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system.
    Tang A; Neeman E; Vuong B; Arasu VA; Liu R; Kuehner GE; Savitz AC; Lyon LL; Anshu P; Seaward SA; Patel MD; Habel LA; Kushi LH; Mentakis M; Thomas ES; Kolevska T; Chang SB;
    Breast Cancer Res Treat; 2022 Feb; 191(3):665-675. PubMed ID: 34988767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer diagnosis and treatment during the COVID-19 pandemic in a nationwide, insured population.
    Caswell-Jin JL; Shafaee MN; Xiao L; Liu M; John EM; Bondy ML; Kurian AW
    Breast Cancer Res Treat; 2022 Jul; 194(2):475-482. PubMed ID: 35624175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.